Cardiac defects have not been noted in the seven previously reported PCD families with DNAAF1 mutations (17,18), but our families appear to have a higher rate than would be expected in an unselected PCD cohort, for which the incidence of CHD is currently estimated at 3.5–6% of cases (14). This evidence concerns the gene DNAAF1 and primary ciliary dyskinesia.